Unlocking the Potential of GLP-1s: Who's Eligible and What's Next?
Imagine a world where millions of Americans could potentially shed pounds and manage their diabetes with a single injection. At least 57 million privately insured adults under the age of 65 could be eligible for GLP-1s, a class of weight loss and diabetes medications. GLP-1s are approved to treat